Le Lézard
Classified in: Health
Subject: TRD

Newtopia to Present at the Bloom Burton & Co. Healthcare Investor Conference


TORONTO, April 19, 2022 /CNW/ - Newtopia Inc. ("Newtopia" or the "Company") (TSXV: NEWU) (OTCQB: NEWUF), a tech-enabled habit change provider focused on preventing, slowing and reversing chronic disease, today announced that Jeff Ruby, Founder and CEO, will participate in the Bloom Burton & Co. Healthcare Investor Conference taking place at the Metro Toronto Convention Centre, North Building on May 2nd and 3rd, 2022.

Jeff Ruby, Founder and CEO, will present at 3:00 PM ET on Tuesday, May 3 as well as host investor meetings throughout the two-day conference. The presentation will be webcast live and can be accessed on the Investor Relations' section of Newtopia's website, investor.newtopia.com.

In addition, a copy of the Company's most recent investor presentation is posted in the News & Events section of the Company's investor relations website.

About Newtopia

Newtopia is a tech-enabled habit change provider focused on disease prevention and reducing the cost of care for health insurers. As a provider of whole person care, we prevent, reverse and slow the progression of chronic disease while enriching mental health, resilience and overall human performance. Newtopia's programs leverage genetic, social and behavioral insights to create individualized prevention programs with a focus on type 2 diabetes, heart disease, stroke and weight. With a person-centered approach that combines virtual care, digital tools, connected devices and actionable data science, Newtopia delivers sustainable clinical and financial outcomes. Newtopia serves some of the largest nationwide employers and health plans and is currently listed on the Toronto Stock Exchange (TSXV: NEWU) (OTCQB: NEWUF). To learn more, visit newtopia.com, LinkedIn or Twitter.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Newtopia Inc.


These press releases may also interest you

at 06:00
Anti-Migrating Agent Market worth $224 million by 2029 - Exclusive Report by MarketsandMarketstm
The report "Anti-Migrating Agent Market by Type (Non-ionic, Anionic, Cationic, Amphoteric), Grades (Technical, Food, Pharmaceutical), Application, Chemistry (Organic, Inorganic), End-Use Industry (Textile, Plastics, Paper), and Region - Global...

at 05:42
Gupshup and Meta along with Sudan Medical Specialization Board and Shabaka launch Telemedicine Chatbot for Sudanese Refugees
Gupshup, the world's leading Conversation Cloud, in collaboration with Meta, the Sudan Medical Specialization Board and non-profit Shabaka today announced the launch of a telemedicine chatbot providing healthcare access for Sudanese refugees in...

at 05:23
ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q2 2024
The revenue in June for Zinzino's sales markets increased by 13% and amounted to SEK 148.5 (131.4) million. Faun Pharma's external sales decreased and amounted to SEK 5.8 (8.5) million. Overall, the Group increased revenues by 10% to SEK 154.3...

at 05:00
Specialty Enzymes Market worth $9.2 billion by 2029 - Exclusive Report by MarketsandMarketstm
The global Specialty Enzymes Market size is estimated to be valued at USD 6.1 billion in 2024 and is projected to reach USD 9.2 billion by 2029, recording a CAGR of 8.5% from 2024 to 2029 according to a report published by MarketsandMarketstm. The...

at 05:00
Danish start-up Kvantify secures EUR 10 million seed round to unlock quantum computing potential, starting with life sciences
Kvantify, a leading quantum software start-up, has announced the successful closure of a EUR 10 million seed round. This funding will enable Kvantify to strengthen its position as a global leader in quantum computing, with an initial focus on...

at 04:37
Cytotoxic Drugs and HPAPI Manufacturing Market worth USD 27.1 Billion to 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cytotoxic Drugs and HPAPI Manufacturing  Market- (Type of Product (HPAPI and highly potent finished dosage form), Company Size (Small, Mid-sized, Large,...

More news about Health...


News published on and distributed by: